-
公开(公告)号:US20050037445A1
公开(公告)日:2005-02-17
申请号:US10482029
申请日:2002-06-19
申请人: Hans Poulsen , Nina Pedersen , Shila Mortensen , Susanne Sorensen , Mikkel Pedersen , Henrik Elsner
发明人: Hans Poulsen , Nina Pedersen , Shila Mortensen , Susanne Sorensen , Mikkel Pedersen , Henrik Elsner
IPC分类号: A61K38/00 , A61K39/00 , A61K39/39 , A61K47/48 , A61K48/00 , A61P35/00 , A61P35/02 , C07K14/705 , C12N15/09 , C12N15/10 , C12Q1/02 , C12Q1/68 , G01N33/15 , G01N33/50 , G01N33/53 , G01N33/566 , G01N33/574
CPC分类号: G01N33/5011 , A61K38/00 , A61K39/00 , C12N15/1034 , C12Q1/6809 , C12Q1/6886 , C12Q1/6897 , G01N33/57492 , G01N2500/20 , C12Q2527/125
摘要: The present invention describes methods for identification of molecules expressed at a different level on the cell surface of cancer cells compared to non-malignant cells and methods of identification of cancer specific promoters to be used singly or in combination for delivery and expression of therapeutic genes for treatment of cancer. The invention furthermore describes targeting complexes targeted to cell surface molecules identified by the methods of the invention. In embodiments of the invention said targeting complexes comprise the promoters identified by the methods of the invention. In addition the invention describes methods of identifying binding partners for the cell surface molecules and the binding partners per se. Methods of treatment using the targeting complexes and uses of the targeting complexes for the preparation of a medicament arc also disclosed by the invention. Furthermore, the invention describes uses of the cell surface molecules or fragments thereof for preparation of vaccines.
摘要翻译: 本发明描述了与非恶性细胞相比,用于鉴定在癌细胞的细胞表面上以不同水平表达的分子的方法以及用于单独使用或组合用于递送和表达治疗基因的癌症特异性启动子的鉴定方法 治疗癌症。 本发明进一步描述了靶向通过本发明方法鉴定的细胞表面分子的复合物。 在本发明的实施方案中,所述靶向复合物包含通过本发明的方法鉴定的启动子。 此外,本发明描述了鉴定细胞表面分子和结合配偶体本身的结合配偶体的方法。 本发明还公开了使用靶向复合物的治疗方法和靶向复合物用于制备药物电弧的用途。 此外,本发明描述了细胞表面分子或其片段用于制备疫苗的用途。